Ashraf Badros
Professor · University of Maryland Capital Region Health
Credentials: · · ·
History
- 1988–1990
Medical Oncology
- 1985–1988
Internal Medicine
- 1981–1985
Doctor of Medicine
Research
Nature Medicine · 2015 · 722 citations
The Lancet Oncology · 2020 · 657 citations
Blood · 2001 · 436 citations
34 papers
26 papers
- BB
23 papers
21 papers
21 papers
18 papers
- EA
16 papers
15 papers
Grants
- 2010–2014
Role of Salivary Bisphosphonates in Osteonecrosis of the Jaw in Myeloma Patients
National Institute of Dental and Craniofacial Research · R21
Contact PI · $344.9K · University of Maryland Baltimore
- 2007–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $156.7K · University of Maryland Baltimore
Clinical trials
- 2025–2032
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Principal investigator · Recruiting · Phase 1, Phase 2
University of Maryland, Baltimore
- 2021–2024
Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Principal investigator · Terminated · Phase 1, Phase 2
University of Maryland, Baltimore
- 2014–2017
Principal investigator · Terminated · Phase 1, Phase 2
Ashraf Badros
- 2005
Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)